Pierre Massion
Faculty Member
Last active: 1/11/2018

Biomarkers and molecular testing for early detection, diagnosis, and therapeutic prediction of lung cancer.

Pass HI, Beer DG, Joseph S, Massion P
Thorac Surg Clin. 2013 23 (2): 211-24

PMID: 23566973 · DOI:10.1016/j.thorsurg.2013.01.002

The search for biomarkers in the management of lung cancer involves the use of multiple platforms to examine changes in gene, protein, and microRNA expression. Multiple studies have been published in an attempt to describe early detection, diagnostic, prognostic, and predictive biomarkers using chiefly tissues and blood elements. Studies are characterized by a lack of commonality of specific biomarkers, and a lack of validated, clinically useful markers. The future of biomarker discovery as a means of tailoring therapy for patients with lung cancer will involve next-generation sequencing along with collaborative efforts to integrate and validate candidate markers.

Copyright © 2013 Elsevier Inc. All rights reserved.

MeSH Terms (5)

Biomarkers, Tumor Early Detection of Cancer Humans Lung Neoplasms Prognosis

Connections (1)

This publication is referenced by other Labnodes entities: